NRL-4 (Neurelis)

N/A

Report date: 2025/01/26 17:24:31
NME

Base Information

Drug NameNRL-4 (Neurelis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAgitationSchizophreniaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurelis Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurelis Inc
Inactive CompaniesN/A
Active IndicationsAgitationSchizophreniaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A